Ncardia at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Ncardia brings 2 presentations to SfN 2026 in Washington, and exhibits at Booth 417. Its presentations centre on human iPSC-derived models for translational neuroscience, preclinical safety testing, and neurodegenerative disease. One thread explores 3D microphysiological systems alongside models of α-synuclein, TAU, and TDP-43 aggregation.

OrganizationSfN 2026 Attendance
Ncardia
Leiden, Netherlands
ncardia.com
Antibody and reagent companies
Provides human iPSC-derived cell models and contract research services for drug discovery and safety testing.
Booth
Exhibiting at Booth 417
Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm
Poster
Mon Nov 16
1–5pm
Poster
Wed Nov 18
8am–noon

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ncardia

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction